Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.

from Health and Science https://ift.tt/zIGN8EY
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L